Expert Opinion on Therapeutic Targets 2014-10-01

Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expression.

Chiao-Wen Lin, Ying-Erh Chou, Hui-Ling Chiou, Mu-Kuan Chen, Wei-En Yang, Ming-Ju Hsieh, Shun-Fa Yang

Index: Expert Opin. Ther. Targets 18(10) , 1109-20, (2014)

Full Text: HTML

Abstract

Polyphenol compounds, present in a wide variety of natural plants, exhibit antioxidant and free radical scavenging ability and induce apoptosis in various cancer cells. However, the effect of pterostilbene on oral cancer cell metastasis has not been clarified.The present study aimed to examine the anti-metastatic properties of pterostilbene in human oral squamous cell carcinoma (SCC)-9 cells.In this study, pterostilbene treatment significantly inhibited migration/invasion capacities of SCC-9 cells in vitro. The results of zymography and western blotting revealed that the activities and protein levels of the MMP-2 and urokinase-type plasminogen activator (u-PA) was inhibited by pterostilbene. Western blot analysis also showed that pterostilbene inhibits the phosphorylation of Akt, extracellular signal-regulated kinase 1/2 and p38. Determinations of the mRNA levels, real-time polymerase chain reaction and promoter assays were conducted to evaluate the inhibitory effects of pterostilbene on MMP-2 and u-PA expression in SCC-9 cells. Such inhibitory effects were associated with the upregulation of tissue inhibitor of metalloproteinase-2, plasminogen activator inhibitor-1 and the downregulation of the transcription factors of NF-κB, SP-1 and CREB signaling pathways.Pterostilbene may have potential use as a chemopreventive agent against oral cancer metastasis.